GLP-1 Drug Market region
Despite robust growth, the GLP-1 drug market faces several challenges. High costs limit patient access in many regions, and manufacturing complexities can restrict supply. Ensuring equitable access while maintaining profitability remains a central concern for pharmaceutical companies.
Patient education is another barrier, as some individuals may hesitate to adopt injectable therapies or understand the benefits. Overcoming these challenges requires targeted strategies involving policy support, insurance coverage, and awareness campaigns. For more information, consult the GLP-1 Drug Market report.